258 related articles for article (PubMed ID: 400727)
21. Effect of somatostatin on fasting and glucose-stimulated gastric inhibitory polypeptide release in man.
Salera M; Pironi L; Giacomoni P; Venturi S; Capelli M; Miglioli M; Barbara L
Digestion; 1982; 24(2):126-32. PubMed ID: 6127273
[TBL] [Abstract][Full Text] [Related]
22. Gastric inhibitory polypeptide and insulin release in response to oral and intravenous glucose in coeliac disease.
Lauritsen KB; Lauritzen JB; Christensen KC
Scand J Gastroenterol; 1982 Mar; 17(2):241-5. PubMed ID: 6753103
[TBL] [Abstract][Full Text] [Related]
23. Interaction of fat-stimulated gastric inhibitory polypeptide on pancreatic alpha and beta cell function.
Verdonk CA; Rizza RA; Nelson RL; Go VL; Gerich JE; Service FJ
J Clin Invest; 1980 May; 65(5):1119-25. PubMed ID: 6988457
[TBL] [Abstract][Full Text] [Related]
24. The enteric enhancement of glucose-stimulated insulin release. The role of GIP in aging, obesity, and non-insulin-dependent diabetes mellitus.
Elahi D; Andersen DK; Muller DC; Tobin JD; Brown JC; Andres R
Diabetes; 1984 Oct; 33(10):950-7. PubMed ID: 6383904
[TBL] [Abstract][Full Text] [Related]
25. Hypersecretion of gastric inhibitory polypeptide in nondiabetic children with cystic fibrosis.
Ross SA; Morrison D; McArthur RG
Pediatrics; 1981 Feb; 67(2):252-4. PubMed ID: 7017571
[TBL] [Abstract][Full Text] [Related]
26. Diminished immunoreactive gastric inhibitory polypeptide response to a meal in newly diagnosed type I (insulin-dependent) diabetics.
Krarup T; Madsbad S; Moody AJ; Regeur L; Faber OK; Holst JJ; Sestoft L
J Clin Endocrinol Metab; 1983 Jun; 56(6):1306-12. PubMed ID: 6341393
[TBL] [Abstract][Full Text] [Related]
27. Beta-adrenergic stimulation and blockade of the release of gastric inhibitory polypeptide and insulin in man.
Flaten O; Sand T; Myren J
Scand J Gastroenterol; 1982 Mar; 17(2):283-8. PubMed ID: 6127792
[TBL] [Abstract][Full Text] [Related]
28. Oral glucose tolerance, insulin and gastric inhibitory polypeptide secretion in patients recovered from acute myocardial infarction.
Larsen S; Lauritsen KB; Christiansen I
Diabetologia; 1981 Sep; 21(3):235-6. PubMed ID: 7028554
[TBL] [Abstract][Full Text] [Related]
29. The effects of xylitol on the secretion of insulin and gastric inhibitory polypeptide in man and rats.
Salminen S; Salminen E; Marks V
Diabetologia; 1982 Jun; 22(6):480-2. PubMed ID: 7049804
[TBL] [Abstract][Full Text] [Related]
30. Effect of graded intraduodenal glucose infusions on the release and physiological action of gastric inhibitory polypeptide.
McCullough AJ; Miller LJ; Service FJ; Go VL
J Clin Endocrinol Metab; 1983 Feb; 56(2):234-41. PubMed ID: 6337173
[TBL] [Abstract][Full Text] [Related]
31. Influence of ingested load on postprandial insulin secretion. Rôle of gastric inhibitory polypeptide (GIP).
Beck B; Villaume C
Arch Int Physiol Biochim; 1985 Jun; 93(2):101-6. PubMed ID: 2412503
[TBL] [Abstract][Full Text] [Related]
32. Gastric emptying and release of incretin hormones after glucose ingestion in humans.
Schirra J; Katschinski M; Weidmann C; Schäfer T; Wank U; Arnold R; Göke B
J Clin Invest; 1996 Jan; 97(1):92-103. PubMed ID: 8550855
[TBL] [Abstract][Full Text] [Related]
33. Hypersecretion of gastric inhibitory polypeptide following oral glucose in diabetes mellitus.
Ross SA; Brown JC; Dupré J
Diabetes; 1977 Jun; 26(6):525-9. PubMed ID: 324834
[TBL] [Abstract][Full Text] [Related]
34. Gastric inhibitory polypeptide secretion after radical pancreatoduodenectomy.
Miyata M; Nakao K; Tanaka Y; Sakamoto T; Hamaji M; Taketani H; Kawashima Y
Ann Surg; 1984 Mar; 199(3):281-5. PubMed ID: 6367676
[TBL] [Abstract][Full Text] [Related]
35. The effect of oral galactose on GIP and insulin secretion in man.
Morgan LM; Wright JW; Marks V
Diabetologia; 1979 Apr; 16(4):235-9. PubMed ID: 428694
[TBL] [Abstract][Full Text] [Related]
36. Immunoreactive gastric inhibitory polypeptide response to a meal during the first eighteen months after diagnosis of type 1 (insulin dependent) diabetes mellitus.
Krarup T; Madsbad S; Moody AJ
J Clin Endocrinol Metab; 1985 Jan; 60(1):120-5. PubMed ID: 3880559
[TBL] [Abstract][Full Text] [Related]
37. The response of plasma gastric-inhibitory polypeptide (GIP) to slow and fast glucose ingestion in Billroth II resected patients and normal controls.
Jorde R; Schulz TB; Burhol PG; Schulz LB
Regul Pept; 1981 Nov; 2(6):391-9. PubMed ID: 7029674
[TBL] [Abstract][Full Text] [Related]
38. Gastric inhibitory polypeptide (GIP) hypersecretion in obesity depends on meal size and is not related to hyperinsulinemia.
Ebert R; Creutzfeldt W
Acta Diabetol Lat; 1989; 26(1):1-15. PubMed ID: 2665406
[TBL] [Abstract][Full Text] [Related]
39. Gastric inhibitory polypeptide (GIP) and insulin release in response to oral and intravenous glucose in uremic patients.
Lauritzen JB; Lauritsen KB; Olsen ME; Timmerman I
Metabolism; 1982 Nov; 31(11):1096-9. PubMed ID: 6752641
[TBL] [Abstract][Full Text] [Related]
40. Gastric inhibitory polypeptide (GIP) and insulin release in the obese Zucker rat.
Chan CB; Pederson RA; Buchan AM; Tubesing KB; Brown JC
Diabetes; 1984 Jun; 33(6):536-42. PubMed ID: 6373459
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
